John Zalcberg

Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysis.

Sze-Ee Soh, Renata Morello, Darshini Ayton, Susannah Ahern, Ri Scarborough, Claire Zammit, Margaret Brand, Robert G Stirling, John Zalcberg

Journal article  |  2021  |  Health Qual Life Outcomes

BACKGROUND: The 12-item Short-Form Health Survey version 2 (SF-12v2), a widely used, generic patient-reported measure of health st..

Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards

Eva Segelov, Christine Carrington, Sanchia Aranda, David Currow, John R Zalcberg, Alexander G Heriot, Linda Mileshkin, John Coutsouvelis, Jeremy L Millar, Brian T Collopy, Jon D Emery, Phoebe Zhang, Simon Cooper, Carmel O'Kane, Janet Wale, Stephen J Hancock, Anthony Sulkowski, John Bashford

Journal article  |  2021  |  MEDICAL JOURNAL OF AUSTRALIA

INTRODUCTION: The Australian Council on Healthcare Standards (ACHS) sponsored an expert-led, consensus-driven, four-stage process,..

Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis.

Rob G Stirling, Cerys Chau, Ali Shareh, John Zalcberg, Barbara M Fischer

Journal article  |  2021  |  J Thorac Oncol

INTRODUCTION: Patients with NSCLC may be treated with curative intent, yet they remain at high risk of both disease recurrence and..

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆.

PG Casali, A Le Cesne, AP Velasco, D Kotasek, P Rutkowski, P Hohenberger, E Fumagalli, IR Judson, A Italiano, H Gelderblom, N Penel, JT Hartmann, F Duffaud, D Goldstein, J Martin-Broto, A Gronchi, E Wardelmann, S Marréaud, JR Zalcberg, S Litière, et al.

Journal article  |  2021  |  Ann Oncol

BACKGROUND: In 2004, we started an intergroup randomized trial of adjuvant imatinib versus no further therapy after R0-R1 surgery ..

The acceleration of ageing in older patients with cancer.

Jaidyn Muhandiramge, Suzanne Orchard, Andrew Haydon, John Zalcberg

Journal article  |  2021  |  J Geriatr Oncol

Older cancer survivors may experience ageing at an accelerated rate when compared to their similar-aged, cancer-free counterparts...

Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

John J McNeil, Peter Gibbs, Suzanne G Orchard, Jessica E Lockery, Wendy B Bernstein, Yin Cao, Leslie Ford, Andrew Haydon, Brenda Kirpach, Finlay Macrae, Catriona McLean, Jeremy Millar, Anne M Murray, Mark R Nelson, Galina Polekhina, Christopher M Reid, Ellen Richmond, Luz Maria Rodriguez, Raj C Shah, Jeanne Tie, et al.

Journal article  |  2021  |  JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

BACKGROUND: ASPirin in Reducing Events in the Elderly, a randomized, double-blind, placebo-controlled trial of daily low-dose aspi..

Putting the "good" into Good Clinical Practice

Tanya Symons, Steve Webb, John R Zalcberg

Journal article  |  2021  |  MEDICAL JOURNAL OF AUSTRALIA

Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial

Jonathan M Loree, Anthony Dowers, Dongsheng Tu, Derek J Jonker, Daniel L Edelstein, Hannah Quinn, Frank Holtrup, Timothy Price, John R Zalcberg, Malcolm J Moore, Christos S Karapetis, Chris J O'Callaghan, Paul Waring, Hagen F Kennecke, Stanley R Hamilton, Scott Kopetz

Journal article  |  2021  |  CLINICAL CANCER RESEARCH

PURPOSE: Expanded RAS/BRAF mutations have not been assessed as predictive for single-agent cetuximab in metastatic colorectal canc..

Ripretinib for the treatment of advanced gastrointestinal stromal tumor.

John R Zalcberg

Journal article  |  2021  |  Therap Adv Gastroenterol

Gastrointestinal stromal tumors (GISTs) are rare tumors of the gastrointestinal (GI) tract yet represent the most common GI sarcom..

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, Timothy Price, Ralf D Hofheinz, Bernard Nordlinger, Jean-Francois Daisne, Jos Janssens, Baruch Brenner, Hans Reinel, Stephan Hollerbach, Karel Caca, Florian Fauth, Carla V Hannig, John Zalcberg, Niall Tebbutt, Murielle E Mauer, Sandrine Marreaud, Manfred P Lutz, Karin Haustermans

Journal article  |  2021  |  JOURNAL OF CLINICAL ONCOLOGY

PURPOSE: The PETACC 6 trial investigates whether the addition of oxaliplatin to preoperative capecitabine-based chemoradiation and..